NCT03466333View on ClinicalTrials.gov

Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia

PHASE2CompletedINTERVENTIONAL

Enrollment

118

Participants

Timeline

Start Date

September 5, 2018

Primary Completion Date

September 11, 2020

Study Completion Date

September 11, 2020

Conditions

Cardiovascular DiseasesPre-Eclampsia Onset Less Than 37 Weeks (Diagnosis)

Interventions

DRUG

Enalapril Maleate

Enalapril maleate will be encapsulated; participants will take the drug once a day for 6 months following delivery.

DRUG

Placebo oral capsule

The placebo will be encapsulated; participants will take the drug once a day for 6 months following delivery. It will be identical in appearance to the IMP.

Trial Locations (1)

M13 9WL

Manchester University NHS Foundation Trust, Manchester

All Listed Sponsors

lead

Manchester University NHS Foundation Trust

OTHER_GOV

NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia | Biotech Hunter | Biotech Hunter